Donald Trump has rescinded an executive order from President Joe Biden that sought to lower the price of drugs.

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact Medicaid and Medicare initiatives.

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe Biden on lowering prescription drug costs in posts online that suggest President Donald Trump has canceled the $35 insulin co-pay cap for certain Medicare programs.

President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the Centers for Medicare and Medicaid Services and perhaps a substantive shake-up in two of the largest federal social welfare programs.

After major backlash, Trump’s radical plan to freeze government spending is on hold. Now, it’s all very confusing and somewhat opaque — which, under Trump, is by design — but here’s what appears to have happened: We often forget that Trump has frequently been cowed by public opinion when it turns against him.

Trump stopped a program that had been in the works and was intended to give Medicare recipients access to more than 100 generic drugs for $2 a month, according to another executive order signed on Trump's first day in his new term.

President Donald Trump issued a flurry of executive orders during the first ... one of the orders revoked was one that lowered prescription drug costs for people on Medicare and Medicaid. Several VERIFY readers asked us if these posts are true.

Despite online claims, President Donald Trump’s executive orders did not include removing Medicare’s $35 monthly out-of-pocket price cap, which is set by law.

The president is promising a return to meritocracy—while staffing his government with underqualified loyalists.

Robert F. Kennedy Jr.'s second confirmation hearing highlights vaccine skepticism, bipartisan concerns, and his plans as health secretary nominee.

Consumer sentiment fell in January for the first time in six months, according to U-M survey. What's next as Trump creates more uncertainty?